Literature DB >> 8952507

Interdependent domains controlling the enzymatic activity of mitogen-activated protein kinase kinase 1.

S J Mansour1, J M Candia, J E Matsuura, M C Manning, N G Ahn.   

Abstract

The activation of human mitogen-activated protein kinase kinase 1 (MKK1) is achieved by phosphorylation at Ser218 and Ser222 within a regulatory loop. Partial activation was achieved by replacing these residues with aspartic/glutamic acid. Higher activity was obtained by introducing four acidic residue substitutions in the regulatory loop, indicating that acidic residues in the loop stabilize an active configuration by the introduction of negative charge. Activation of MKK1 is also achieved by deleting residues 44-51, N-terminal to the consensus catalytic core. Although substitution of residues within this segment by alanine does not affect activity, introduction of proline residues elevates kinase activity, indicating that activation results from perturbation of secondary structure within residues 44-51. Pseudosubstrate inhibition, a commonly observed mechanism of kinase regulation, is not operative in this process. Both the acidic substitutions and the N-terminal deletion increase Vmax, V/K(m),ERK2, and V/K(m),ATP, as is also observed following phosphorylation of wild-type MKK1. A synergistic enhancement of these steady-state rate parameters occurs upon combining the mutations, suggesting that conformational changes induced by mutagenesis together mimic those seen upon phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8952507     DOI: 10.1021/bi961854s

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  46 in total

1.  Distinct, constitutively active MAPK phosphatases function in Xenopus oocytes: implications for p42 MAPK regulation In vivo.

Authors:  M L Sohaskey; J E Ferrell
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

2.  A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission.

Authors:  A J Bardwell; L J Flatauer; K Matsukuma; J Thorner; L Bardwell
Journal:  J Biol Chem       Date:  2000-12-28       Impact factor: 5.157

3.  Inhibition of mitogen-activated kinase signaling sensitizes HeLa cells to Fas receptor-mediated apoptosis.

Authors:  T H Holmström; S E Tran; V L Johnson; N G Ahn; S C Chow; J E Eriksson
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

4.  MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly.

Authors:  T H Holmström; I Schmitz; T S Söderström; M Poukkula; V L Johnson; S C Chow; P H Krammer; J E Eriksson
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

5.  Active erk regulates microtubule stability in H-ras-transformed cells.

Authors:  R E Harrison; E A Turley
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

6.  Phosphorylation-dependent changes in structure and dynamics in ERK2 detected by SDSL and EPR.

Authors:  Andrew N Hoofnagle; James W Stoner; Thomas Lee; Sandra S Eaton; Natalie G Ahn
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

7.  Suppression of integrin activation by activated Ras or Raf does not correlate with bulk activation of ERK MAP kinase.

Authors:  Paul E Hughes; Beat Oertli; Malene Hansen; Fan-Li Chou; Berthe M Willumsen; Mark H Ginsberg
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

8.  Detection of multistability, bifurcations, and hysteresis in a large class of biological positive-feedback systems.

Authors:  David Angeli; James E Ferrell; Eduardo D Sontag
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

9.  Protein kinase involved in flagellar-length control.

Authors:  Martin Wiese; Daniela Kuhn; Christoph G Grünfelder
Journal:  Eukaryot Cell       Date:  2003-08

10.  Regulation of protein phosphorylation within the MKK1-ERK2 complex by MP1 and the MP1*P14 heterodimer.

Authors:  Amrita Brahma; Kevin N Dalby
Journal:  Arch Biochem Biophys       Date:  2007-01-04       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.